Trials Leadership

Experts Leading the Way

Building on GCAR’s experience developing and executing master protocol and platform trials, GCAR is working with a committed group of oncologists, statisticians, pathologists, neurosurgeons, imaging experts, advocates, and researchers from academia, industry, and government for all its collaborations and initiatives.

Brian M. Alexander, MD, MPH

Global Coalition for Adaptive Research
Foundation Medicine
Harvard Medical School
Dana-Farber Cancer Institute


Derek C. Angus , MD, MPH, FRCP

UPMC and University of Pittsburgh School of Medicine
University of Pittsburgh


David Arons, JD

National Brain Tumor Society


Sujuan Ba, PhD

National Foundation for Cancer Research
Asian Fund for Cancer Research
AIM-HI Accelerator Fund


Donald A. Berry, PhD

The University of Texas MD Anderson Cancer Center
Berry Consultants


Scott Berry, MS, PhD

Berry Consultants


Nicholas A. Blondin, MD

Smilow Cancer Hospital and
Yale Comprehensive Cancer Center


Meredith Buxton, PhD, MPH

Global Coalition for Adaptive Research 


Tim Cloughesy, MD

Global Coalition for Adaptive Research
UCLA, Jonsson Comprehensive Cancer Center
David Geffen School of Medicine


Howard Colman, MD, PhD

Huntsman Cancer Institute
University of Utah


John de Groot, MD

UCSF Hellen Diller Family Comprehensive Cancer Center
University of California San Francisco


Macarena De la Fuente, MD

Sylvester Comprehensive Cancer Center
University of Miami Miller School of Medicine 


Benjamin Ellingson, PhD

UCLA, Jonsson Comprehensive Cancer Center
David Geffen School of Medicine


Hui Gan, MBBS, PhD

Olivia Newton-John Cancer Research Institute
Austin Health


Gary B. Gordon, MD, PhD

Global Coalition for Adaptive Research


David Huang, MD, MPH

University of Pittsburgh School of Medicine


Beth Y. Karlan, MD

UCLA, Jonsson Comprehensive Cancer Center
David Geffen School of Medicine


Lance Kawaguchi

Cure Brain Cancer Foundation 


Mustafa Khasraw, MD

Duke Cancer Institute


Andrew B. Lassman, MD

Columbia University Vagelos College of Physicians and Surgeons
Herbert Irving Comprehensive Cancer Center


Eudocia Q. Lee, MD, MPH

Harvard Medical School
Dana-Farber Cancer Institute


Wenbin Li, MD

Beijing Tiantan Hospital Cancer Center
Capital Medical University


Michael Lim, MD

Stanford University


Andrew W. Lo, PhD

MIT Sloan School of Management


Ursula A. Matulonis, MD

Dana-Farber Cancer Institute
Harvard Medical School


Florian B. Mayr, MD, MPH

University of Pittsburgh 


Bryan J. McVerry, MD

University of Pittsburgh School of Medicine


Ingo K. Mellighoff, MD, FACP

Memorial Sloan Kettering Cancer Center


Tom Mikkelsen, MD

Henry Ford Cancer Institute


Ashik Mohan, MS

Getinge MedTech


Robert F. Murray, III 

Global Coalition for Adaptive Research


Kunle Odunsi, MD, PhD

University of Chicago Medicine


David M. O’Malley, MD

The Ohio State University Comprehensive Cancer Center, The James


James Perry, MD, FRCPC

Sunnybrook Research Institute
University of Toronto


Tracey Roberts, BSN

Global Coalition for Adaptive Research


Lynda D. Roman, MD

Keck School of Medicine of USC


Christopher W. Seymour, MD, MSC

University of Pittsburgh 


Anil K. Sood, MD

The University of Texas MD Anderson Cancer Center


Erik P. Sulman, MD, PhD

NYU Grossman School of Medicine
NYU Langone’s Perlmutter Cancer Center


Kirk Tanner, PhD

National Brain Tumor Society


Michael Weller, MD

University Hospital Zurich


Patrick Y. Wen, MD

Dana-Farber Cancer Institute
Harvard Medical School


W.K. Alfred Yung, MD

The University of Texas MD Anderson Cancer Center